ISR — ISR Immune System Regulation Holding AB (publ) Share Price
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | n/a | n/a | n/a | n/a | n/a | 137 | 103 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | -46.15 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
ISR Immune System Regulation Holding AB (publ) is a Sweden-based research company within the area of immunotherapy. The Company is focused the development of drug therapies for viral infections, in particular human immunodeficiency virus (HIV). The Company's product candidate, ISR048, is undergoing phase II of clinical trials for HIV indications. It provides a resistance profile, which does not require co-dosing with a boosting agent. A second generation anti-HIV drug candidate, ISR049, is in preclinical development. The Company's another drug candidate in development, ISR050, shows immunostimulatory properties that are being explored in vitro and in animal models of chronic infections, such as tuberculosis.
Directors
- Last Annual
- December 31st, 2022
- Last Interim
- December 31st, 2022
- Incorporated
- January 1st, 1970
- Public Since
- March 24th, 2017
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 69,008,951
- Address
- Retzius vag 11, SOLNA, 171 65
- Web
- https://israb.se/
- Phone
- Contact
- Ola Winqvist
- Auditors
- Ohrlings PricewaterhouseCoopers AB
Upcoming Events for ISR
ISR Immune System Regulation Holding AB (publ) Annual Shareholders Meeting
Similar to ISR
2cureX AB
OMX Nordic Exchange Stockholm
Abliva AB
OMX Nordic Exchange Stockholm
Acousort AB
OMX Nordic Exchange Stockholm
Active Biotech AB publ
OMX Nordic Exchange Stockholm
AddLife AB
OMX Nordic Exchange Stockholm
FAQ
What is the ISR Immune System Regulation Holding AB (publ) share price?
As of Today at 01:11 UTC, shares in ISR Immune System Regulation Holding AB (publ) are trading at SEK1.40. This share price information is delayed by 15 minutes.
How has the ISR Immune System Regulation Holding AB (publ) share price performed this year?
Shares in ISR Immune System Regulation Holding AB (publ) last closed at SEK1.40 and the price had moved by -85.96% over the past 365 days. In terms of relative price strength the ISR Immune System Regulation Holding AB (publ) share price has underperformed the FTSE Global All Cap Index by -86.67% over the past year.
What are the analyst and broker recommendations for ISR Immune System Regulation Holding AB (publ)?
There is no consensus recommendation for this security.
Find out moreWhat is the ISR Immune System Regulation Holding AB (publ) dividend yield?
ISR Immune System Regulation Holding AB (publ) does not currently pay a dividend.
Does ISR Immune System Regulation Holding AB (publ) pay a dividend?
ISR Immune System Regulation Holding AB (publ) does not currently pay a dividend.
When does ISR Immune System Regulation Holding AB (publ) next pay dividends?
ISR Immune System Regulation Holding AB (publ) does not currently pay a dividend.
How do I buy ISR Immune System Regulation Holding AB (publ) shares?
To buy shares in ISR Immune System Regulation Holding AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of ISR Immune System Regulation Holding AB (publ)?
As of the previous close price of SEK1.40, shares in ISR Immune System Regulation Holding AB (publ) had a market capitalisation of .
Where are ISR Immune System Regulation Holding AB (publ) shares listed?
Here are the trading details for ISR Immune System Regulation Holding AB (publ):
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: ISR
What kind of share is ISR Immune System Regulation Holding AB (publ)?
Based on an overall assessment of its quality, value and momentum ISR Immune System Regulation Holding AB (publ) is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a ISR Immune System Regulation Holding AB (publ) share price forecast for 2023?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the ISR Immune System Regulation Holding AB (publ) share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ISR Immune System Regulation Holding AB (publ). Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -76.3%.
As of the last closing price of SEK1.40, shares in ISR Immune System Regulation Holding AB (publ) were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the ISR Immune System Regulation Holding AB (publ) PE Ratio?
The ISR Immune System Regulation Holding AB (publ) PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK1.40.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of ISR Immune System Regulation Holding AB (publ)?
ISR Immune System Regulation Holding AB (publ)'s management team is headed by:
- Anders Milton - CHM
- Ola Winqvist - CEO
- Gunnar Modalen - CFO
- Hans Glise - DRC
- Gunnar Jardelov - DRC